Company Overview
In 1994, Université libre de Bruxelles (ULB) decided to lay down roots in Wallonia and to build a molecular biology research centre on the Aeropole of Charleroi, near to the Brussels South Airport. This was achieved in 1999, by the opening of the Institute of Molecular Biology and Medicine (IBMM).

Today, Biopark Charleroi Brussels South counts more than 1300 employees, all active in the biomedical and biotechnology fields. It gathers together two universities, Université libre de Bruxelles (ULB) and Université de Mons (UMONS) and involves about 50 organisations in 4 activity sectors:

(i) Three dedicated RESEARCH centres: the Institute of Molecular Biology and Medicine (IBMM), the Institute for Medical Immunology (IMI) and the Centre for Microscopy and Molecular Imaging (CMMI).

(ii) Two units help scientists to find practical APPLICATIONS for the results of their research: the ULB’s Technology Transfer Office and the I-Tech Incubator S.A.

(iii) More than forty seven COMPANIES including a-ULaB, Antigone, Bioxodes, Bone Therapeutics, BoneVet, Caprion Bioscience, Delphi Genetics, DNAVision, Endo Tools Therapeutics, ImmunXperts, the Institute of Pathology and Genetic (IPG), iTeos Therapeutics, MaSTercell, NCardia, Novasep, Ogeda, OncoDNA, Orgenesis, Ovizio, SynAbs, Syngulon, Tools4Patients, Univercells and various services companies.

(iV) HeLSci Biopark, a TRAINING centre, provides a broad range of courses, both short and long, for those involved at all levels of the Life Sciences sector (scientists, technicians, Ph.D. students, professors, and jobseekers).

Having all these different facilities available on a single site presents numerous advantages, including mutually beneficial relationships and the creation of a solid professional network. All of this makes the Biopark an ideal setting for partnerships between universities, specialist schools, as well as public and private partners.

The Biopark’s comprehensive and dynamic approach makes it a significant contributor to the socio-economic development of Wallonia by creating local, regional and international partnerships, dedicated to scientific development and biomed-biotech technological applications.